MERCER GLOBAL ADVISORS INC /ADV

Position in GERN — Geron Corp

CIK 853758 DENVER, CO

Position in GERN

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$79,242

-$43,405 QoQ

Shares Held

61,908

-24.8% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#140

of 258 holders

Holding Since

Jun 2021

15 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

MERCER GLOBAL ADVISORS INC /ADV holds $302,411,362 across 140 Biotechnology names. GERN ranks #116 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	941,283	$124,936,492
2	CAPR	Capricor Therapeutics, Inc.	802,732	$19,329,786
3	ORMP	Oramed Pharmaceuticals Inc.	3,810,540	$18,328,697
4	VRTX	Vertex Pharmaceuticals Inc / Ma	30,705	$15,252,094
5	INCY	Incyte Corp	116,207	$13,173,225
6	REGN	Regeneron Pharmaceuticals, Inc.	20,126	$12,549,366
7	EXEL	Exelixis, Inc.	176,339	$9,594,604
8	CORT	Corcept Therapeutics Inc	102,823	$8,940,459

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$79,242	61,908	-24.8%	Shares	Sole	2026-08-19
2026-03-31	$122,647	82,314	-10.2%	Shares	Sole	2026-05-15
2025-12-31	$120,937	91,619	+104.4%	Shares	Sole	2026-02-18
2025-09-30	$61,400	44,818	-2.3%	Shares	Sole	2025-11-14
2025-06-30	$64,671	45,866	+9.2%	Shares	Sole	2025-08-14
2025-03-31	$66,784	42,003	-6.0%	Shares	Sole	2025-05-15
2024-12-31	$158,142	44,673	+0.6%	Shares	Sole	2025-02-14
2024-09-30	$201,548	44,394	+59.9%	Shares	Sole	2024-11-14
2022-12-31	$67,171	27,757	-64.3%	Shares	Sole	2023-02-09
2022-09-30	$181,951	77,757	-38.1%	Shares	Sole	2022-11-15
2022-06-30	$194,714	125,622	0.0%	Shares	Sole	2022-08-10
2022-03-31	$170,845	125,622	+125.8%	Shares	Sole	2022-05-10
2021-12-31	$67,858	55,622	+26.1%	Shares	Sole	2022-02-04
2021-09-30	$60,437	44,115	0.0%	Shares	Sole	2021-11-10
2021-06-30	$62,202	44,115	—	Shares	Sole	2021-08-10
No filing history on record for this holder in this stock.